After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Acumen Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Acumen Pharmaceuticals Inc is $114.48M. A total of 0.31 million shares were traded on the day, compared to an average of 213.33K shares.
In the most recent transaction, Zuga Matt sold 6,888 shares of ABOS for 1.82 per share on Jan 08 ’26. After the transaction, the CFO & Chief Business Officer now owns 209,951 company shares. In a previous transaction on Jan 08 ’26, Barton Russell sold 3,530 shares at 1.86 per share. ABOS shares that Chief Operating Officer owns now total 123,269.
Among the insiders who sold shares, Meisner Derek M disposed of 36,911 shares on Jan 08 ’26 at a per-share price of $1.82. This resulted in the Chief Legal Officer & Corp Sec holding 97,548 shares of ABOS after the transaction. In another insider transaction, Meisner Derek M sold 8,548 shares at $1.71 per share on Jan 12 ’26. Company shares held by the Chief Legal Officer & Corp Sec now total 83,800.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ABOS has a high of $2.46 and a low of $0.86.
As of this writing, ABOS has an earnings estimate of -$0.56 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.44 per share and a lower estimate of -$0.67. The company reported an EPS of -$0.62 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ABOS’s latest balance sheet shows that the firm has $194.24M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $5.15M in liabilities at the time. Its Book Value Per Share was $1.54, while its Total Shareholder’s Equity was $225.18M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
